Podiatry CME

This course is designed for healthcare professionals and those in allied professions who may come into contact with and be called upon to intervene on behalf of victims of human trafficking within the scope of their practice.

According to the 2015 National Survey on Drug Use and Health, approximately 3.8 million people (1.4% of those ages 12 or older) reported misusing prescription pain relievers, while another 329,000 people reported using heroin. Within the same year, 52,404 lethal overdoses took place, making drug overdose the leading cause of accidental death within the United States. Stancliff et al estimated that as of 2012, approximately 80% of people dependent on heroin or prescription opioids were not engaged in any treatment and many in treatment do not use the most effective medication-assisted treatments available to them.

Despite recent increased awareness of opioid use disorder (OUD) and efforts to improve access to care, several barriers to treatment still exist, including financial, geographic, regulatory, and social. In 2012, only 2.2% of physicians in the United States obtained waivers to prescribe buprenorphine for the treatment of OUD. Of those who received waivers, 41.6% were psychiatrists. This may be perceived as a potential barrier to OUD treatment as patients are often resistant to referrals to psychiatric and/or addiction clinics given the stigmas commonly surrounding addiction and mental health. Furthermore, physicians with waivers were found to practice primarily in urban settings, leaving a large portion of the rural population without access to buprenorphine treatment.

With all this in mind, education is needed in regards to current and emerging treatment options for OUD available to multiple patient populations. Also, with the deaths due to drug overdoses still elevated, education on how to recognize and reverse an opioid overdose is needed.

This presentation will address the above needs by discussing the science behind opioid use disorder as well as reflect upon current statistics associated with its impact on the United States. During the discussion, opioid overdose risks will be discussed and participants will be able to practice recognizing key symptoms of an overdose situation. Steps of using naloxone will be discussed and connected to how to appropriately seek out treatment for maintenance of opioid use disorder. Finally, new buprenorphine products and the potential role of naltrexone will be applied to this stigmatized population.

This course discusses the different FDA-approved antibiotics for the treatment of complicated urinary tract infections (UTIs). It talks about the pharmacology, clinical studies, adverse effects, dosage, and administration of Meropenem/Vaborbactam (Vabomere), Plazomicin (Zemdri), and Cefiderocol (Fetroja) for proper use.

This video activity focuses on ways to help early detection of breast cancer by learning the risk factors, the different screening and diagnostic modalities and guidelines to what kind of screening is needed, and most importantly, when should screening begin.

The Live In-Person Desert Foot East Conference returns to Teaneck, New Jersey at the Teaneck Marriott at Glenpointe, April 5 – 6, 2025. The lecture program will be taught by some of the finest teachers in podiatry and will be focused on evidence-based, best practices to improve limb salvage techniques, advanced wound care skills, and treat surgical and medical disorders of the lower limb. The conference provides a great opportunity for you to learn along with a large part of the federal service wound care and surgical community, as well as professionals in acute care, home care, and the private sector. The conference brings together groups involved with limb salvage preservation of the lower extremity, from healthcare clinicians in the private sector, the Veterans Administration, VA Podiatric Residency Directors, Academy of Physicians in Wound Healing (APWH), and the Department of Defense from across the country. The most unique part of the conference is the rotating interactive hands-on workshops, that focus on advanced technologies that provide our attendees with hands-on practical experience and training on surgical procedures, advanced wound care, and new techniques in healing the lower extremity that you will bring back to your offices to begin using on Monday morning. This important annual conference is estimated for 12 CE/CME/CECH for all podiatric surgeons, surgical residents, MDs, DOs, NPs, PAs, and WOCNs, and 2 ABPM MOC Points.

Hotel Indigo Los Angeles, Los Angeles, CA
The PRESENT Treasure Hunt Conference 2025 will be a live in-person event February 22 – 23 at the Hotel Indigo Downtown Los Angeles. The content will follow the traditional Treasure Hunt format of Practice Management, Medicare, and Insurance Updates, with the addition of cutting-edge CME education and Workshops for a total of 12.5 CME Credits and 2 ABPM MOC Points. Gabriel Halperin, DPM will give his traditional Medicare Update.

GIBLIB is an on-demand streaming medical education platform where physicians and advanced practice providers go to learn and earn CME through convenient, high-quality educational content created by trusted experts from the world’s top hospitals.

With this purchase, you get a 1-year subscription to GIBLIB and the following features:

• Earn unlimited AMA PRA Category 1 Credits™
• Full library access to thousands of videos across all specialties
• Personalized and curated video recommendations
• Cross-device viewing on web and iOS
• New content released and available every week
• Create custom playlists that you can personally curate
• Bookmark videos for later viewing
• Take notes on specific content and review for later
• View transcripts of all videos, available in multiple languages

This course provides 2 AMA PRA Category 1 Credit for license renewal and talks about the pharmacology, adverse effects, dosage, and administration of FDA-approved treatments for acute pain like nonopioid analgesics, adjuvant pain medications, migraine medicines, Tramadol/Celecoxib (Seglentis), Bupivacaine/Meloxicam (Zynrelef), IV Meloxicam (Anjeso), and Benzhydrocodone/Acetaminophen (Apadaz).

This course provides 1 AMA PRA Category 1 Credit for license renewal. Vaginal infections can cause pain and discomfort. Without treatment, they may lead to complications that can adversely affect a person’s health. From bacterial vaginosis to sexually transmitted infections, learn more about a few of the most common types of vaginal infections and symptoms here. This activity provides recommendations for the management of most sexually transmitted infections (STIs) other than HIV and viral hepatitis and FDA-approved treatments for bacterial vaginosis like Tinidazole (Tindamax) and Secnidazole (Solosec).

From October to December, 2022, 50% of the proceeds from this course will be donated to the National Breast Cancer Foundation. Despite the advances in breast cancer detection and treatment, on the psychological side, clinicians who have been involved in the emotional care of cancer patients can report that a breast cancer diagnosis can nevertheless generate many concerns for patients, as well as their families. Psychological interventions for breast cancer patients have well-documented success in reducing distress and enhancing psychosocial adaptation to disease. As such, these interventions have been highlighted as important mechanisms by which physical health can be improved. This activity focuses on the common issues that impact psychological adjustment to breast cancer and interventions that will help optimize care in the cancer context.

There is a growing prevalence of breast cancer among adolescents and young adults (AYAs) aged 15 to 39 years old, and people of color (POCs). Breast cancer tends to present as more advance and aggressive forms in both of these demographics and is unfortunately associated with higher mortality rates than other populations in whom mortality rates have been decreasing over the last few decades.

This activity highlights the current trends, challenges, and health disparities experienced by AYAs and POCs with breast cancer, and provides insight into possible ways of improving screening and overall management of these patients.